ARCA biopharma, Inc.·4

Nov 23, 4:53 PM ET

Ozeroff Christopher David 4

4 · ARCA biopharma, Inc. · Filed Nov 23, 2021

Insider Transaction Report

Form 4
Period: 2021-11-22
Ozeroff Christopher David
EVP & General Counsel
Transactions
  • Purchase

    Common Stock

    2021-11-22$2.26/sh+50,000$113,21050,970 total
Footnotes (1)
  • [F1]The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $2.21 to $2.329. Upon request of the SEC staff, ARCA biopharma, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased at each separate price.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT